Certara Expands Biosimulation Market with AI-Driven QSP Platform
Certara, Inc. (CERT)
Company Research
Source: GlobeNewswire
RADNOR, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara IQ, a scalable, AI-powered Quantitative Systems Pharmacology (QSP) solution. QSP has rapidly become a cornerstone of modern drug discovery and development with QSP-based FDA submissions having nearly doubled every 1.4 years since 2013.1 QSP combines computational modeling and experimental data to examine how a drug interacts with biological systems and disease processes, enabling scientists to predict critical outcomes such as optimal dosing, therapeutic window, and ideal patient populations. These capabilities are especially critical for novel or complex modalities. “Certara IQ represents the next step in making biosimulation a foundational capability across the entire drug discovery and development value chain,” said William F. Feehery, Chief Executive Officer. “By uniting AI, systems modeling and scientific expert
Show less
Read more
Impact Snapshot
Event Time:
CERT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CERT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CERT alerts
High impacting Certara, Inc. news events
Weekly update
A roundup of the hottest topics
CERT
News
- Certara (NASDAQ:CERT) was upgraded by analysts at Rothschild Redb to a "strong-buy" rating.MarketBeat
- Certara (NASDAQ:CERT) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=CERT&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> frMarketBeat
- Certara (NASDAQ:CERT) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $10.00 price target on the stock.MarketBeat
- Certara (NASDAQ:CERT) was given a new $10.00 price target on by analysts at Redburn Partners.MarketBeat
- Certara (NASDAQ:CERT) had its "sell (d+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
CERT
Earnings
- 11/6/25 - Beat
CERT
Sec Filings
- 11/25/25 - Form SCHEDULE
- 11/12/25 - Form 4
- 11/6/25 - Form 10-Q
- CERT's page on the SEC website